Sign Out
Pregnancy Risk factor: A.
Folic acid is usually indicated in the treatment of megaloblastic anemias of pregnancy. Folic acid requirements are increased during pregnancy; a deficiency may result in fetal harm. Studies in pregnant women have not shown that Folic acid increases the risk of abnormalities if administered during pregnancy. During lactation, Folic acid requirement is markedly increased. Folic acid is excreted in the milk of lactating mothers. No adverse effects have been observed in breast-fed infants whose mothers were receiving Folic acid.
Continue with Google